FAAS
VIRX

First Allied Advisory Services’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

First Allied Advisory Services’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-437
Closed -$43K – 1245
2018
Q1 		$43K Buy
+437
New +$43K ﹤0.01% 1153